4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-23-003172
President & CEO sold 100,000 shares at $10.38 ($1,038,000)
- President & CEO acquired 100,000 shares (option exercise)
- President & CEO gave 10,000 shares (gift)
- President & CEO gave 10,000 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
Stonehouse Jon P · President & CEO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-29 | Gift : show line 1 in the form | −10,000 | 1,008,739 | D | ||
| 2022-12-29 | Gift : show line 2 in the form | +5,000 | 10,000 | I | ||
| 2022-12-29 | Gift : show line 3 in the form | +5,000 | 10,000 | I | ||
| 2023-02-01 | Exercise or conversion : show line 4 in the form | +100,000 | $5.45 | $545,000 | 1,108,739 | D |
| 2023-02-01 | Sale : show line 5 in the form | −100,000 | $10.38 | $1,038,000 | 1,008,739 | D |
| Open-market sales · 100,000 sh · avg $10.38 · $1,038,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-01 | Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) | −100,000 | 0 | D |
Loading xslF345X03/form4.xml…